Cargando…
Radiation effects on uptake of 99Tcm-hexamethylpropylen amine oxime (HMPAO) in head and neck tumours.
Twenty patients with malignant head and neck tumours were imaged with 99Tcm-labelled hexamethylpropylene amine oxime (HMPAO), a radiopharmaceutical generally used for blood flow studies. Before radiotherapy (RT), 93% of the tumours could be detected with single photon emission computed tomography (S...
Autores principales: | Minn, H., Ahonen, A., Paul, R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977700/ https://www.ncbi.nlm.nih.gov/pubmed/1911222 |
Ejemplares similares
-
Increased uptake of 99mTc-HMPAO in necrotic brain tumors.
por: Lee, S. H., et al.
Publicado: (1998) -
Diagnosis of bone infection by complementary role of technetium-99m MDP and technetium-99m hexamethylpropylene-amineoxime-leukocytes
por: Al-Zahrani, Abdullah, et al.
Publicado: (2012) -
Technetium-99m HMPAO and SPECT in the assessment of blood flow in human lung tumours.
por: Rowell, N. P., et al.
Publicado: (1989) -
Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO
por: de Vries, Erik F. J., et al.
Publicado: (2010) -
Erratum to: Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO
por: de Vries, Erik F. J., et al.
Publicado: (2010)